- Home
- PLRX vs CYH Comparison
PLRX vs CYH Comparison
Compare PLRX & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- CYH
- Stock Information
- Founded
- PLRX 2015
- CYH 1985
- Country
- PLRX United States
- CYH United States
- Employees
- PLRX N/A
- CYH N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- CYH Hospital/Nursing Management
- Sector
- PLRX Health Care
- CYH Health Care
- Exchange
- PLRX Nasdaq
- CYH Nasdaq
- Market Cap
- PLRX 680.3M
- CYH 440.4M
- IPO Year
- PLRX 2020
- CYH 1991
- Fundamental
- Price
- PLRX $11.37
- CYH $3.20
- Analyst Decision
- PLRX Strong Buy
- CYH Hold
- Analyst Count
- PLRX 7
- CYH 6
- Target Price
- PLRX $40.50
- CYH $4.40
- AVG Volume (30 Days)
- PLRX 485.5K
- CYH 1.9M
- Earning Date
- PLRX 02-26-2025
- CYH 02-18-2025
- Dividend Yield
- PLRX N/A
- CYH N/A
- EPS Growth
- PLRX N/A
- CYH N/A
- EPS
- PLRX N/A
- CYH N/A
- Revenue
- PLRX N/A
- CYH $12,551,000,000.00
- Revenue This Year
- PLRX N/A
- CYH $1.16
- Revenue Next Year
- PLRX N/A
- CYH $1.18
- P/E Ratio
- PLRX N/A
- CYH N/A
- Revenue Growth
- PLRX N/A
- CYH 0.81
- 52 Week Low
- PLRX $10.22
- CYH $2.51
- 52 Week High
- PLRX $18.00
- CYH $6.29
- Technical
- Relative Strength Index (RSI)
- PLRX 44.60
- CYH 45.86
- Support Level
- PLRX $10.35
- CYH $3.20
- Resistance Level
- PLRX $11.07
- CYH $3.39
- Average True Range (ATR)
- PLRX 0.61
- CYH 0.16
- MACD
- PLRX 0.06
- CYH 0.02
- Stochastic Oscillator
- PLRX 43.50
- CYH 47.14
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About CYH Community Health Systems Inc.
Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.